SENSIENT TECHNOLOGIES CORP (SXT)
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SXT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SXT | Director | 71 | ["Interim President, University of Florida (2025-present)","Member of the faculty of Columbia University (1985-2025) (on extended leave)","Professor of Medicine at Columbia University’s College of Physicians and Surgeons (2004-2025)","Founding Director, Center for Human Longevity at Columbia University (2023-2025)","Chair of the Department of Medicine at Columbia University and Physician-in-Chief at NewYork-Presbyterian/Columbia University Medical Center (2008-2023)","Director of the Division of Experimental Therapeutics at Columbia Medical Center (1998-2021)","Founding director of Tonix Pharmaceuticals, Inc. (2007-2011)","Co-founder of Vela Pharmaceuticals, a private company that developed drugs for central nervous system disorders","Co-founder of Tegrigen Therapeutics, LLC","Member of the President’s Council on Bioethics during the George W. Bush administration","Awarded the Presidential Citizens Medal (2008)","Elected to the National Academy of Inventors (2016)","Expert in the medical and pharmaceutical fields"] | ["Compensation and Development Committee","Nominating and Corporate Governance Committee","Scientific Advisory Committee"] | 2026 |